Quidel recalls Lyra Covid test due to high risk of false negative results

Health, Fitness & Food

A man inquires about a coronavirus disease (COVID-19) test at a mobile testing van in Brooklyn, New York, U.S., June 2, 2021.
Brendan McDermid | Reuters

Quidel is recalling its Lyra Covid-19 Assay test due to a high risk of false negative results in patients who actually have high amounts of the virus.

Quidel is a company that produces diagnostic healthcare products around the world. The Covid test was given emergency use authorization by the Food and Drug Administration in March. It uses a swab sample from nasal area to detect RNA that is specific for the SARS-CoV-2 virus.

“False negative results may lead to delayed diagnosis or inappropriate treatment of SARS-CoV-2 that may cause patient harm, serious illness, and death,” the FDA wrote on its website announcing the recall.

False negative results could also lead to further spread of the virus in a community and puts other high-risk individuals at risk of injury or death.

Quidel has received five complaints about the product, but there are currently no reports of injury or death from its use. The company’s shares slumped by about 5% in afterhours trading.

Products You May Like

Articles You May Like

Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
Simone Biles Thinks Jordan Chiles Should’ve Gotten a 10 on This Vault
Citing ‘death threats,’ Texas judge asked attorneys to keep news of hearing on legality of abortion pill quiet
FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people
FDA authorizes Pfizer’s Covid omicron booster as fourth shot for kids under 5

Leave a Reply

Your email address will not be published.